GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 33 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $6,768,456 | -30.3% | 2,942,807 | -2.4% | 0.15% | -32.7% |
Q3 2022 | $9,713,000 | -41.0% | 3,016,371 | +0.8% | 0.22% | -4.8% |
Q2 2022 | $16,465,000 | +202.6% | 2,993,695 | +28.2% | 0.23% | +273.8% |
Q1 2022 | $5,442,000 | -48.5% | 2,335,476 | +33.4% | 0.06% | -37.8% |
Q4 2021 | $10,574,000 | -34.3% | 1,750,707 | +50.8% | 0.10% | -36.8% |
Q3 2021 | $16,102,000 | +24.2% | 1,160,891 | +16.4% | 0.16% | +33.6% |
Q2 2021 | $12,964,000 | -4.6% | 997,238 | +13.0% | 0.12% | -7.9% |
Q1 2021 | $13,595,000 | – | 882,768 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 10,881,144 | $31,337,695 | 3.43% |
Sio Capital Management, LLC | 2,081,216 | $5,993,902 | 1.86% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,375,000 | $3,960,000 | 1.58% |
TCG Crossover Management, LLC | 3,038,889 | $8,752,000 | 1.29% |
Logos Global Management LP | 2,525,000 | $7,272,000 | 0.97% |
SPHERA FUNDS MANAGEMENT LTD. | 1,531,497 | $4,410,711 | 0.80% |
Orbimed Advisors | 9,308,726 | $26,809,131 | 0.57% |
GREAT POINT PARTNERS LLC | 579,667 | $1,669,441 | 0.30% |
Temasek Holdings (Private) Ltd | 9,901,940 | $28,517,587 | 0.17% |
TANG CAPITAL MANAGEMENT LLC | 159,087 | $458,171 | 0.06% |